These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 11905629)
1. The dangers of subgroup analysis. Stephens R Lancet Oncol; 2001 Jan; 2(1):9. PubMed ID: 11905629 [No Abstract] [Full Text] [Related]
2. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice? Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074 [No Abstract] [Full Text] [Related]
3. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic. Chang MN; Shuster JJ Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402 [TBL] [Abstract][Full Text] [Related]
4. Strategy for randomised clinical trials in rare cancers. Tan SB; Dear KB; Bruzzi P; Machin D BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959 [TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation. Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570 [TBL] [Abstract][Full Text] [Related]
6. Strength of accumulating evidence and data monitoring committee decision making. George SL; Freidlin B; Korn EL Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949 [TBL] [Abstract][Full Text] [Related]
7. [Responsibilities of biostatistics for evaluation of treatment results in tumor therapy]. Guggenmoos-Holzmann I Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():65-8. PubMed ID: 1983629 [TBL] [Abstract][Full Text] [Related]
9. Statistical considerations for the next generation of clinical trials. Wu W; Shi Q; Sargent DJ Semin Oncol; 2011 Aug; 38(4):598-604. PubMed ID: 21810519 [TBL] [Abstract][Full Text] [Related]
11. [Design and conduct of randomized controlled trials (RCTs)]. Park DH; Baik SK Korean J Hepatol; 2006 Sep; 12(3):309-14. PubMed ID: 16998284 [No Abstract] [Full Text] [Related]
12. A guide to sample size and interim analysis in clinical trials. Rademaker AW Contemp Urol; 1994 Feb; 6(2):43-4. PubMed ID: 10146676 [No Abstract] [Full Text] [Related]
13. Panel discussion 1. Dickersin K; Williams G; George S Clin Trials; 2012 Dec; 9(6):696-704. PubMed ID: 23250943 [No Abstract] [Full Text] [Related]
14. Diagnostics for assumptions in moderate to large simple clinical trials: do they really help? Ganju J Stat Med; 2006 May; 25(10):1799-800. PubMed ID: 16639774 [No Abstract] [Full Text] [Related]
15. Intention-to-treat or efficacy analysis? Horne D Br J Gen Pract; 2003 Apr; 53(489):324; author reply 324-5. PubMed ID: 12879836 [No Abstract] [Full Text] [Related]